AtheroGenics
Latest round
- Series C
Last raised
- Sep 1999
Total raised
- $22M
Investors
- 6
About AtheroGenics
AtheroGenics, Inc. engages in discovery and development of drugs for inflammatory diseases.
Who invested in AtheroGenics
6 investors across 4 rounds
See all investors in AtheroGenics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AtheroGenics
Who invested in AtheroGenics?
AtheroGenics has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AtheroGenics raised?
AtheroGenics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did AtheroGenics last raise money?
AtheroGenics's most recent round on record is a Series C, in Sep 1999.
What does AtheroGenics do?
AtheroGenics is a pharmaceuticals company.
Where is AtheroGenics headquartered?
AtheroGenics is headquartered in Alpharetta, US.
Which VCs invest in companies like AtheroGenics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at AtheroGenics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like AtheroGenics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.